Orthopaedic Surgery in New Port Richey, FL
3 verified orthopaedic surgery doctors in New Port Richey.
Orthopedic surgeons diagnose and treat conditions of the bones, joints, ligaments, tendons, and muscles.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Peter Candelora, MD
Orthopaedic Surgery
CMS Open Payments· $14,616 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$14,616
Total received
3
Transactions
2
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Peter Candelora do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Fuller, MD
Orthopaedic Surgery
CMS Open Payments· $1,366 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,366
Total received
15
Transactions
3
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to John Fuller do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jared Shouppe, MD
Orthopaedic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.